Logos Global Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-400,000
| Closed | -$10.7M | – | 47 |
|
|
2024
Q4 | $10.7M | Sell |
400,000
-50,000
| -11% | -$1.34M | 1.25% | 28 |
|
|
2024
Q3 | $12M | Buy |
+450,000
| New | +$12M | 1.3% | 26 |
|
|
2024
Q1 | – | Sell |
-950,000
| Closed | -$10.4M | – | 54 |
|
|
2023
Q4 | $10.4M | Buy |
+950,000
| New | +$10.4M | 0.97% | 20 |
|
|
2022
Q3 | – | Sell |
-150,000
| Closed | -$1.19M | – | 41 |
|
|
2022
Q2 | $1.19M | Sell |
150,000
-63,744
| -30% | -$507K | 0.22% | 25 |
|
|
2022
Q1 | $2.07M | Sell |
213,744
-636,256
| -75% | -$6.17M | 0.27% | 33 |
|
|
2021
Q4 | $13M | Buy |
850,000
+168,188
| +25% | +$2.57M | 1.34% | 22 |
|
|
2021
Q3 | $10.8M | Sell |
681,812
-550,000
| -45% | -$8.67M | 0.78% | 31 |
|
|
2021
Q2 | $26.3M | Buy |
1,231,812
+175,000
| +17% | +$3.73M | 2.21% | 18 |
|
|
2021
Q1 | $34.3M | Buy |
+1,056,812
| New | +$34.3M | 3.35% | 8 |
|